Cantel Medical (CMN) 77.16 $CMN
Cantel Medical Promotes Seth M. Yellin to Executive Vice President
PR Newswire - Thu Sep 01, 8:00AM CDT
CANTEL MEDICAL CORP. (NYSE:CMN) is pleased to announce that Seth M. Yellin has recently been promoted to Executive Vice President, Strategy and Corporate Development from Senior Vice President, Corporate Development. In his new role, Mr. Yellin will have responsibility for Cantel's strategic planning function along with his current role of corporate development, which includes leading the Company's active acquisition program.
CMN: 77.16 (+1.21)
Cantel Medical to Present at the 7th Annual Credit Suisse Small & Mid Cap Conference
PR Newswire - Thu Sep 01, 7:00AM CDT
CANTEL MEDICAL CORP. (NYSE: CMN) announced today that Jorgen B. Hansen, President and CEO, will be presenting at the 7th Annual Credit Suisse Small & Mid Cap Conference at the Waldorf Astoria in New York City. The formal presentation is scheduled for Wednesday, September 14, 2016 at 4:10 p.m., EDT. In addition, management will be available for separate one-on-one meetings during the day.
CMN: 77.16 (+1.21)
SmarTrend Watching for Potential Pullback in Shares of Cantel Medical After 3.26% Gain
Comtex SmarTrend(R) - Mon Aug 29, 4:14PM CDT
Cantel Medical (NYSE:CMN) traded in a range yesterday that spanned from a low of $72.53 to a high of $75.00. Yesterday, the shares gained 3.3%, which took the trading range above the 3-day high of $73.14 on volume of 190,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CMN: 77.16 (+1.21)
Cantel Medical Acquires Accutron, Inc.
PR Newswire - Mon Aug 01, 1:00PM CDT
CANTEL MEDICAL CORP. (NYSE:CMN), a leading global company dedicated to delivering innovative infection prevention products and services, today announced that it has acquired Accutron, Inc., the industry leading manufacturer of nitrous oxide delivery systems and single-use nasal masks, for a purchase price of approximately $52.5 million in cash consideration.
CMN: 77.16 (+1.21)
Cantel Medical Names Jorgen B. Hansen as New President and CEO
PR Newswire Europe - Mon Aug 01, 7:02AM CDT
CANTEL MEDICAL CORP. announced today the appointment of Jorgen B. Hansen as the Company's President and Chief Executive Officer, effective today, consistent with the Company's long-term CEO succession plan. Mr. Hansen also will become a member of the Board of Directors. Mr. Hansen succeeds Andrew A. Krakauer, who will serve as a Senior Advisor for the Company until October 15, 2016.
CMN: 77.16 (+1.21)
Cantel Medical Announces Appointment of Dr. Ronnie Myers to its Board of Directors
PR Newswire - Fri Jun 17, 11:25AM CDT
Cantel Medical Corp. (NYSE:CMN) today announced the appointment of Dr. Ronnie Myers as a member of its Board of Directors, effective June 16.
CMN: 77.16 (+1.21)
Cantel Medical Board of Directors Authorizes Regular Semiannual Dividend
PR Newswire - Thu Jun 16, 9:59AM CDT
Cantel Medical Corp. (NYSE:CMN) today announced that its Board of Directors authorized a regular semiannual cash dividend of $0.06 per outstanding share of the Company's Common Stock. The dividend is payable on July 29, 2016 to shareholders of record at the close of business on July 15, 2016.
CMN: 77.16 (+1.21)
Cantel Medical (CMN) Q3 Earnings & Sales Up, Shares Fall
Zacks Equity Research - Zacks Investment Research - Tue Jun 14, 8:23AM CDT
Cantel Medical Corp. (CMN) reported adjusted earnings of 44 cents per share, which surged 25.7% from the year-ago quarter.
IRMD: 17.31 (-0.30), MASI: 59.90 (+0.47), CRY: 16.23 (+0.39), CMN: 77.16 (+1.21)
Company News for June 09, 2016
Zacks Equity Research - Zacks Investment Research - Thu Jun 09, 9:10AM CDT
Companies in the News are: PLAY,PAY,CMN,GEF
PLAY: 46.60 (+0.36), PAY: 16.81 (-3.29), GEF: 46.08 (+0.77), CMN: 77.16 (+1.21)
Cantel Medical Announces Record Financial Results for Third Quarter 2016
PR Newswire - Wed Jun 08, 7:00AM CDT
CANTEL MEDICAL CORP. (NYSE: CMN) today reported US GAAP net income of $14,019,000, or $0.34 per diluted share, on a 22.8% increase in sales to a record $173,703,000 for the third quarter ended April 30, 2016. This compares with US GAAP net income of $12,356,000 or $0.30 per diluted share, on sales of $141,508,000 for the third quarter ended April 30, 2015. For the nine months ended April 30, 2016, the Company reported record US GAAP net income of $43,662,000, or $1.05 per diluted share on a 17.4% increase in sales to a record $485,753,000. This compares with US GAAP net income of $34,680,000, or $0.83 per diluted share, on sales of $413,749,000 for the nine months ended April 30, 2015.
CMN: 77.16 (+1.21)
Investor Calendar Invites You to the Cantel Medical Corp. Third Quarter 2016 Earnings Conference Call and Webcast Live on Wednesday, June 8, 2016
ACCESSWIRE - Tue Jun 07, 3:05PM CDT
LITTLE FALLS, NJ / ACCESSWIRE / June 7, 2016 / Cantel Medical Corp. (NYSE: CMN) will host a conference call and live webcast to discuss the results of the third quarter 2016, to be held Wednesday, June 8, 2016 at 11:00 AM Eastern Time.
CMN: 77.16 (+1.21)
/C O R R E C T I O N -- Cantel Medical Corp./
PR Newswire - Thu Jun 02, 10:10AM CDT
In the news release, Cantel Medical Corp. To Hold Conference Call To Discuss Results For Its Third Quarter Ended April 30, 2016, issued June 1, 2016 by Cantel Medical Corp. over PR Newswire, we are advised by the company that the conference call date in the first and second paragraph should be "Wednesday, June 8" rather than "Thursday, June 8" as originally issued inadvertently. The complete, corrected release follows:
CMN: 77.16 (+1.21)
Cantel Medical Corp. To Hold Conference Call To Discuss Results For Its Third Quarter Ended April 30, 2016
PR Newswire - Wed Jun 01, 10:04AM CDT
CANTEL MEDICAL CORP. (NYSE: CMN) will release the results for its third quarter ended April 30, 2016 on Thursday, June 8 before the market opens, and hold a conference call to discuss the results at 11:00 AM ET.
CMN: 77.16 (+1.21)
Cantel Medical to Present at the Jefferies 2016 Global Healthcare Conference
PR Newswire - Mon May 23, 11:03AM CDT
Cantel Medical Corp. (NYSE:CMN) announced today that Jorgen B. Hansen, President and CEO-elect, will be presenting at the Jefferies 2016 Global Healthcare Conference at the Grand Hyatt in New York City. The formal presentation is scheduled for Tuesday, June 7, 2016 at 11:30 a.m. EDT. In addition, management will be available for separate one-on-one meetings during the day.
CMN: 77.16 (+1.21)
Cantel Medical To Present At The 15th Annual Needham & Company Healthcare Conference
PR Newswire - Wed Mar 30, 9:44AM CDT
CANTEL MEDICAL CORP. (NYSE: CMN) announced today that Jorgen B. Hansen, President and Chief Operating Officer, will be presenting at the 15th Annual Needham & Company Healthcare Conference at the Westin Grand Central Hotel in New York. The formal presentation is scheduled for Wednesday, April 13, 2016 at 12:10 p.m. ET. In addition, management will be available for separate one-on-one meetings during the day.
CMN: 77.16 (+1.21)
Cantel Medical Subsidiary, Mar Cor Purification, Launches New Dialysis Water Transport System
PR Newswire - Wed Mar 30, 7:00AM CDT
Mar Cor Purification announced the release of its new ROVER(TM) Portable Dialysis Water Transport System, the first all-plastic, dialysis water cart designed specifically for the hospital environment. The cart was developed to streamline the transport of water purification equipment used in acute hemodialysis procedures and to eliminate the possibility of deterioration associated with metal carts. The ROVER cart improves the safety and efficiency of delivering a dialysis water treatment system within the hospital. All components are fully integrated into the cart system, making the monitoring of key parameters and execution of daily procedures more convenient. The ROVER System has smooth plastic surfaces, which allow for easy cleaning and disinfection, thereby protecting the patient from infection.
CMN: 77.16 (+1.21)
Cantel Medical To Present At The RBC Capital Markets' 2016 Healthcare Conference
PR Newswire - Wed Feb 10, 10:49AM CST
CANTEL MEDICAL CORP. (NYSE: CMN) announced today that Andrew A. Krakauer, Chief Executive Officer, will be presenting at the RBC Capital Markets' 2016 Healthcare Conference at The New York Palace Hotel. The formal presentation is scheduled for Wednesday, February 24, 2016 at 9:30 a.m. ET. In addition, management will be available for separate one-on-one meetings during the day.
CMN: 77.16 (+1.21)
Cantel Medical To Acquire NAMSA's Sterility Assurance Products Division
PR Newswire - Wed Feb 03, 6:30AM CST
CANTEL MEDICAL CORP. (NYSE: CMN), has entered into a definitive agreement with North American Science Associates, Inc. (NAMSA) to acquire NAMSA's Sterility Assurance Monitoring Products division for $13.5 million in cash consideration. For the year ending December 31, 2015 this business had adjusted sales of $5.7 million. The Sterility Assurance Monitoring Products division manufactures a broad suite of high-quality biological and chemical indicators which are used to accurately monitor the effectiveness of sterilization processes. These indicators are designed primarily for the industrial segment serving medical device, life science and other manufacturers, representing a new end-market for Cantel's Healthcare Disposables segment.
CMN: 77.16 (+1.21)
Cantel Medical Subsidiary Mar Cor Purification Releases New 2016 Online Dialysis Water Catalog
PR Newswire - Tue Jan 19, 7:30AM CST
Mar Cor Purification, a worldwide leader in water, filtration, and disinfection technologies, and the leading provider of hemodialysis water equipment in North America, recently released a new U.S. Dialysis Water Product Digital Catalog - 1st edition, available on the Mar Cor Purification website and at catalog.mcpur.com. The digital version of the catalog provides on demand U.S. list pricing for all catalog products and is designed to improve customer experience by providing faster access to information on Mar Cor dialysis products and services through a more user-friendly and interactive online experience.
CMN: 77.16 (+1.21)
Cantel Medical Promotes Seth M. Yellin to Executive Vice President
PR Newswire - Thu Sep 01, 8:00AM CDT
CANTEL MEDICAL CORP. (NYSE:CMN) is pleased to announce that Seth M. Yellin has recently been promoted to Executive Vice President, Strategy and Corporate Development from Senior Vice President, Corporate Development. In his new role, Mr. Yellin will have responsibility for Cantel's strategic planning function along with his current role of corporate development, which includes leading the Company's active acquisition program.
CMN: 77.16 (+1.21)
Cantel Medical to Present at the 7th Annual Credit Suisse Small & Mid Cap Conference
PR Newswire - Thu Sep 01, 7:00AM CDT
CANTEL MEDICAL CORP. (NYSE: CMN) announced today that Jorgen B. Hansen, President and CEO, will be presenting at the 7th Annual Credit Suisse Small & Mid Cap Conference at the Waldorf Astoria in New York City. The formal presentation is scheduled for Wednesday, September 14, 2016 at 4:10 p.m., EDT. In addition, management will be available for separate one-on-one meetings during the day.
CMN: 77.16 (+1.21)
SmarTrend Watching for Potential Pullback in Shares of Cantel Medical After 3.26% Gain
Comtex SmarTrend(R) - Mon Aug 29, 4:14PM CDT
Cantel Medical (NYSE:CMN) traded in a range yesterday that spanned from a low of $72.53 to a high of $75.00. Yesterday, the shares gained 3.3%, which took the trading range above the 3-day high of $73.14 on volume of 190,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CMN: 77.16 (+1.21)
Cantel Medical Acquires Accutron, Inc.
PR Newswire - Mon Aug 01, 1:00PM CDT
CANTEL MEDICAL CORP. (NYSE:CMN), a leading global company dedicated to delivering innovative infection prevention products and services, today announced that it has acquired Accutron, Inc., the industry leading manufacturer of nitrous oxide delivery systems and single-use nasal masks, for a purchase price of approximately $52.5 million in cash consideration.
CMN: 77.16 (+1.21)
Cantel Medical Names Jorgen B. Hansen as New President and CEO
PR Newswire Europe - Mon Aug 01, 7:02AM CDT
CANTEL MEDICAL CORP. announced today the appointment of Jorgen B. Hansen as the Company's President and Chief Executive Officer, effective today, consistent with the Company's long-term CEO succession plan. Mr. Hansen also will become a member of the Board of Directors. Mr. Hansen succeeds Andrew A. Krakauer, who will serve as a Senior Advisor for the Company until October 15, 2016.
CMN: 77.16 (+1.21)
Cantel Medical Announces Appointment of Dr. Ronnie Myers to its Board of Directors
PR Newswire - Fri Jun 17, 11:25AM CDT
Cantel Medical Corp. (NYSE:CMN) today announced the appointment of Dr. Ronnie Myers as a member of its Board of Directors, effective June 16.
CMN: 77.16 (+1.21)
Cantel Medical Board of Directors Authorizes Regular Semiannual Dividend
PR Newswire - Thu Jun 16, 9:59AM CDT
Cantel Medical Corp. (NYSE:CMN) today announced that its Board of Directors authorized a regular semiannual cash dividend of $0.06 per outstanding share of the Company's Common Stock. The dividend is payable on July 29, 2016 to shareholders of record at the close of business on July 15, 2016.
CMN: 77.16 (+1.21)
Cantel Medical (CMN) Q3 Earnings & Sales Up, Shares Fall
Zacks Equity Research - Zacks Investment Research - Tue Jun 14, 8:23AM CDT
Cantel Medical Corp. (CMN) reported adjusted earnings of 44 cents per share, which surged 25.7% from the year-ago quarter.
IRMD: 17.31 (-0.30), MASI: 59.90 (+0.47), CRY: 16.23 (+0.39), CMN: 77.16 (+1.21)
Company News for June 09, 2016
Zacks Equity Research - Zacks Investment Research - Thu Jun 09, 9:10AM CDT
Companies in the News are: PLAY,PAY,CMN,GEF
PLAY: 46.60 (+0.36), PAY: 16.81 (-3.29), GEF: 46.08 (+0.77), CMN: 77.16 (+1.21)
Cantel Medical Announces Record Financial Results for Third Quarter 2016
PR Newswire - Wed Jun 08, 7:00AM CDT
CANTEL MEDICAL CORP. (NYSE: CMN) today reported US GAAP net income of $14,019,000, or $0.34 per diluted share, on a 22.8% increase in sales to a record $173,703,000 for the third quarter ended April 30, 2016. This compares with US GAAP net income of $12,356,000 or $0.30 per diluted share, on sales of $141,508,000 for the third quarter ended April 30, 2015. For the nine months ended April 30, 2016, the Company reported record US GAAP net income of $43,662,000, or $1.05 per diluted share on a 17.4% increase in sales to a record $485,753,000. This compares with US GAAP net income of $34,680,000, or $0.83 per diluted share, on sales of $413,749,000 for the nine months ended April 30, 2015.
CMN: 77.16 (+1.21)
Investor Calendar Invites You to the Cantel Medical Corp. Third Quarter 2016 Earnings Conference Call and Webcast Live on Wednesday, June 8, 2016
ACCESSWIRE - Tue Jun 07, 3:05PM CDT
LITTLE FALLS, NJ / ACCESSWIRE / June 7, 2016 / Cantel Medical Corp. (NYSE: CMN) will host a conference call and live webcast to discuss the results of the third quarter 2016, to be held Wednesday, June 8, 2016 at 11:00 AM Eastern Time.
CMN: 77.16 (+1.21)
/C O R R E C T I O N -- Cantel Medical Corp./
PR Newswire - Thu Jun 02, 10:10AM CDT
In the news release, Cantel Medical Corp. To Hold Conference Call To Discuss Results For Its Third Quarter Ended April 30, 2016, issued June 1, 2016 by Cantel Medical Corp. over PR Newswire, we are advised by the company that the conference call date in the first and second paragraph should be "Wednesday, June 8" rather than "Thursday, June 8" as originally issued inadvertently. The complete, corrected release follows:
CMN: 77.16 (+1.21)
Cantel Medical Corp. To Hold Conference Call To Discuss Results For Its Third Quarter Ended April 30, 2016
PR Newswire - Wed Jun 01, 10:04AM CDT
CANTEL MEDICAL CORP. (NYSE: CMN) will release the results for its third quarter ended April 30, 2016 on Thursday, June 8 before the market opens, and hold a conference call to discuss the results at 11:00 AM ET.
CMN: 77.16 (+1.21)
Cantel Medical to Present at the Jefferies 2016 Global Healthcare Conference
PR Newswire - Mon May 23, 11:03AM CDT
Cantel Medical Corp. (NYSE:CMN) announced today that Jorgen B. Hansen, President and CEO-elect, will be presenting at the Jefferies 2016 Global Healthcare Conference at the Grand Hyatt in New York City. The formal presentation is scheduled for Tuesday, June 7, 2016 at 11:30 a.m. EDT. In addition, management will be available for separate one-on-one meetings during the day.
CMN: 77.16 (+1.21)
Cantel Medical To Present At The 15th Annual Needham & Company Healthcare Conference
PR Newswire - Wed Mar 30, 9:44AM CDT
CANTEL MEDICAL CORP. (NYSE: CMN) announced today that Jorgen B. Hansen, President and Chief Operating Officer, will be presenting at the 15th Annual Needham & Company Healthcare Conference at the Westin Grand Central Hotel in New York. The formal presentation is scheduled for Wednesday, April 13, 2016 at 12:10 p.m. ET. In addition, management will be available for separate one-on-one meetings during the day.
CMN: 77.16 (+1.21)
Cantel Medical Subsidiary, Mar Cor Purification, Launches New Dialysis Water Transport System
PR Newswire - Wed Mar 30, 7:00AM CDT
Mar Cor Purification announced the release of its new ROVER(TM) Portable Dialysis Water Transport System, the first all-plastic, dialysis water cart designed specifically for the hospital environment. The cart was developed to streamline the transport of water purification equipment used in acute hemodialysis procedures and to eliminate the possibility of deterioration associated with metal carts. The ROVER cart improves the safety and efficiency of delivering a dialysis water treatment system within the hospital. All components are fully integrated into the cart system, making the monitoring of key parameters and execution of daily procedures more convenient. The ROVER System has smooth plastic surfaces, which allow for easy cleaning and disinfection, thereby protecting the patient from infection.
CMN: 77.16 (+1.21)
Cantel Medical To Present At The RBC Capital Markets' 2016 Healthcare Conference
PR Newswire - Wed Feb 10, 10:49AM CST
CANTEL MEDICAL CORP. (NYSE: CMN) announced today that Andrew A. Krakauer, Chief Executive Officer, will be presenting at the RBC Capital Markets' 2016 Healthcare Conference at The New York Palace Hotel. The formal presentation is scheduled for Wednesday, February 24, 2016 at 9:30 a.m. ET. In addition, management will be available for separate one-on-one meetings during the day.
CMN: 77.16 (+1.21)
Cantel Medical To Acquire NAMSA's Sterility Assurance Products Division
PR Newswire - Wed Feb 03, 6:30AM CST
CANTEL MEDICAL CORP. (NYSE: CMN), has entered into a definitive agreement with North American Science Associates, Inc. (NAMSA) to acquire NAMSA's Sterility Assurance Monitoring Products division for $13.5 million in cash consideration. For the year ending December 31, 2015 this business had adjusted sales of $5.7 million. The Sterility Assurance Monitoring Products division manufactures a broad suite of high-quality biological and chemical indicators which are used to accurately monitor the effectiveness of sterilization processes. These indicators are designed primarily for the industrial segment serving medical device, life science and other manufacturers, representing a new end-market for Cantel's Healthcare Disposables segment.
CMN: 77.16 (+1.21)
Cantel Medical Subsidiary Mar Cor Purification Releases New 2016 Online Dialysis Water Catalog
PR Newswire - Tue Jan 19, 7:30AM CST
Mar Cor Purification, a worldwide leader in water, filtration, and disinfection technologies, and the leading provider of hemodialysis water equipment in North America, recently released a new U.S. Dialysis Water Product Digital Catalog - 1st edition, available on the Mar Cor Purification website and at catalog.mcpur.com. The digital version of the catalog provides on demand U.S. list pricing for all catalog products and is designed to improve customer experience by providing faster access to information on Mar Cor dialysis products and services through a more user-friendly and interactive online experience.
CMN: 77.16 (+1.21)
